MD+DI, May 2010, Volume 32, No. 5

May 2010


This Issue's Articles
by: Sherrie Conroy

Trends in discrete packaging for implantable medical devices may help OEMs meet the newest challenges, particularly for cardiac implants.
by: Tom Zemites

A reproducible cleaning and coating process affects a device's ultimate approval, success, and profitability.
by: Jay Tourigny

Exporting certain medical devices to Iran is not only legal, but is also a potentially lucrative market strategy.
by: Michael Gershberg

As devices begin to be thought of as commodities, the importance of customer service will increase. Here are some steps to create a reassuring customer service plan.
by: Sung Pak and Ben Yoder

Having a solid package validation program can prevent failure of combination products.
by: Steven Richter

With changing regulations, a new certification model can guide manufacturers through a product’s entire life cycle.
by: Mark Leimbeck

Assuaging both agency and industry concerns requires a precarious balancing act in the 510(k) overhaul.
by: James G. Dickinson

Medical device OEMs may be going the wrong way with verification and validation testing.
by: Andrew Dallas

Do personalized, genetic-based treatments qualify for patents? What can diagnostics innovators do to protect their technology?
by: Shawn O'Dowd and Steven Yu

AdvaMed’s new chairman wants to put the focus back on innovation and on ensuring patient access to technology.
by: Sherrie Conroy

by: Sherrie Conroy

by: Heather Thompson

by: Lawrence Lloyd

by: Maria Fontanazza


by: Lindsey Rooney

by: Heather Thompson